Previous close | 115.70 |
Open | 118.04 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 116.47 - 119.60 |
52-week range | 90.89 - 135.34 |
Volume | |
Avg. volume | 1,161 |
Market cap | 13.54B |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | 0.45 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the second quarter ended June 30, 2024.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that it has released its 2023 Corporate Responsibility Report, reinforcing the company's longstanding operational excellence across its industry-leading, differentiated Labspace® platform. At the vanguard and heart of the life science industry for over 30 years, Alexa
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that a top 20 pharmaceutical company and longstanding credit tenant has increased its San Diego footprint by nearly 53% with the execution of a 10-year lease for 127,382 RSF, with significant expansion options, for a new R&D center at 10075 Barnes Canyon Road on the S